STAA - STAAR Surgical Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

STAAR Surgical Company

1911 Walker Avenue
Monrovia, CA 91016
United States

IndustryMedical Instruments & Supplies
Full Time Employees475

Key Executives

NameTitlePayExercisedYear Born
Ms. Caren L. MasonCEO, Pres & Director1.39MN/A1954
Ms. Deborah J. AndrewsChief Financial Officer616.49k620.08k1957
Dr. Keith HollidayChief Technology Officer678.25kN/A1963
Mr. Samuel J. GestenChief Legal Officer & Corp. Sec.658.25kN/A1962
Mr. Hans-Martin BlickensdoerferSr. VP of Commercial Operations, Direct Markets- Europe & China626.39kN/A1965
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 6; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.